Abstract
Background: The goal of this study was to update the multidisciplinary review of patients who underwent resection of hepatic metastases of nonseminomatous germ cell esticular carcinoma at the Indiana University Medical Center.
Methods: The study involved retrospective chart review for 57 patients who underwent hepatic resection for treatment of metastatic nonseminomatous testicular carcinoma between June 1974 and May 1996. Patients were categorized ccording to the worst postchemotherapy pathologic diagnosis.
Results: Chemotherapy has been highly effective in curing testicular carcinoma. However, even with platinum-based hemotherapy, one-third of patients either do not achieve complete cures or experience relapses. Since 1965, only 57 of the 2219 patients who underwent postchemotherapy retroperitoneal lymph node dissections for treatment of testicular carcinoma at our center underwent hepatic resection for treatment of metastatic disease. Because teratomas have the propensity to degenerate into sarcomas and can cause symptoms resulting from compression, these lesions must be resected to achieve cures. In addition, the only chance for survival for patients with active disease but normal serum marker levels is with complete resection of the tumor burden.
Conclusions: We conclude that hepatic resection for treatment of metastatic testicular carcinoma is safe and efficacious for all patients except those with elevated marker levels after preoperative chemotherapy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Goulet RJ Jr, Hardacre JM, Einhorn LH, et al. 1990 Hepatic resection for disseminated germ cell carcinoma. Ann Surg 212:290–294.
Nichols C, Einhorn L, William S. 1989 Disseminated testicular cancer: refining the cure. Cancer Chemother 4:227–234.
Loehrer PJ Sr, Lauer R, Roth BJ, et al. 1988 Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med109:540–546.
Loehrer PJ Sr, Einhorn LH, Williams SD. 1986 VP-16 plus ifosfamide plus cisplatin as salvage therapy in refractory germ cell cancer. J Clin Oncol4:528–536.
Loehrer PJ Sr. 1992 Testicular Cancer. In: Brain MC, Carbone PP Current Therapy in Hematology–Oncology, Ed. 4. Decker Philadelphia, 300–305.
Einhorn LH. 1986 Cancer of the testis: a new paradigm. Hosp Pract 21:165–178.
Loehrer PJ Sr. 1991 Salvage therapy in recurrent germ cell cancer. Hematol Oncol Clin North Am5:1211–21.
Murphy BR, Breeden ES, Donohue JP, et al. 1993 Surgical salvage of chemorefractory germ cell tumors. J Clin Oncol11:324–329.
McCaffrey JA, Mazumdar M, Bajorin DF, et al. 1997 Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival. J Clin Oncol15: 2559–2563.
Mandelbaum I, William SD, Einhorn LH. 1980 Aggressive surgical management of testicular carcinoma metastatic to the lungs and mediastinum. Ann Thorac Surg30:224 –229.
Mandelbaum I, Yaw PB, Einhorn LH, et al. 1983 The importance of one–stage median sternotomy and retroperitoneal node dissection in disseminated testicular cancer. Ann Thorac Surg 36:524–528.
Gelderman WAH, Koops SH, Sleijfer DT, et al. 1988Results of adjuvant surgery in patients with stage III and IV nonseminomatous testicular tumors after cisplatin–vinblastine–bleomycin chemotherapy. J Surg Oncol38:227–232.
Meyers WC. 1991Neoplasms of the Liver. In: Sabiston DC Jr Textbook of Surgery: The Biological Basis of Modern Surgical Practice, Ed. 14. WB Saunders Philadelphia, 1008.
Libshitz HI, Jing BS, Wallace S, et al. 1983 Sterilized metastases: a diagnostic and therapeutic dilemma. AJR140:15–19.
Donohue JP, Roth LM, Zachery JM, et al. 1982 Cytoreductive surgery for metastatic testis cancer: tissue analysis of retroperitoneal masses after chemotherapy. J Urol127:1111–1114.
Ahlgren AD, Simrell CR, Triche TJ. 1984 Sarcoma arising in a residual testicular teratoma after cytoreductive chemotherapy. Cancer54:2015–2018.
Ulbright TM, Loehrer PJ, Roth LM, et al. 1984 The development of non–germ cell malignancies within germ cell tumors. Cancer 54:1824–1833.
Loehrer PJ Sr, Hui S, Clark S, et al. 1986 Teratoma following cisplatin–based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation. J Urol135:1183–1189.
Quist HL, Fossa SD, Ous S, et al. 1991 Post–chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer: is it necessary to resect all residual masses? J Urol145:300–303.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hahn, T.L., Jacobson, L., Einhorn, L.H. et al. Hepatic Resection of Metastatic Testicular Carcinoma: A Further Update. Ann Surg Oncol 6, 640–644 (1999). https://doi.org/10.1007/s10434-999-0640-0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-999-0640-0